| P346 | The CD40-TRAF6 axis is the key-regulator of the CD40-CD40L system in neointima formation. |
| 1M.Donners, 1L.Beckers, 2R.Noelle, 1M.Daemen, 1E.Lutgens | |
| 1Dept. of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, NL; 2Dept. of Medical Microbiology and Immunology, Dartmouth Medical School, Hanover, US. | |
|
In this study, we investigated which CD40 signaling intermediates are responsible for the beneficial effects of CD40(L) inhibition in vascular disease. We focused on the CD40 adaptor proteins: the TNF Receptor Association Factors (TRAFs). Male CD40-/- mice containing a human CD40 transgene with(out) mutations at the TRAF2,3 (CD40-T2,3), TRAF6 (CD40-T6) or TRAF2,3,6 (CD40-T2,3,6) binding site on CD40 were generated and fed a normal diet. The right carotid artery was ligated and analyzed after 4 weeks (n=85). Compared to wildtype mice, CD40-/- showed a 75% decrease in neointima formation, a decreased intima/media ratio, lumen area compared to wt mice (table, * p<0.05). In CD40-T6 and CD40-T2,3,6 mice neointimal area and intima-media ratio was significantly decreased compared to CD40-TRAFwt, indicating that the effects on neointima formation are TRAF6-dependent. No significant differences were observed in CD40-T2,3 mice. Cultured bone marrow derived macrophages from CD40-TRAF mice were stimulated for 0, 3 or 8 hrs with LPS (10ng/ml, n=2-4 per group). Real time PCR data showed a decrease in IL-6 and MCP-5 mRNA levels in CD40-T6 and CD40-TRAF2,3,6 macrophages when compared to CD40-TRAFwt macrophages. ELISA analysis showed a decrease in TNFα produced by CD40-T6 macrophages.
These results indicate a crucial role for CD40-TRAF6 interactions in the induction of proinflammatory cytokines in macrophages and the development of neointima. |
| Copyright © 2005 S. Karger AG, Basel. Any further use of this abstract requires written permission from the publisher. |